First Time Loading...
S

Shanghai Haishun New Pharmaceutical Packaging Co Ltd
SZSE:300501

Watchlist Manager
Shanghai Haishun New Pharmaceutical Packaging Co Ltd
SZSE:300501
Watchlist
Price: 12.78 CNY 2.98% Market Closed
Updated: May 9, 2024

Shanghai Haishun New Pharmaceutical Packaging Co Ltd
Net Income (Common)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shanghai Haishun New Pharmaceutical Packaging Co Ltd
Net Income (Common) Peer Comparison

Comparables:
C
1378
600219
A
601600
000807
002532

Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
S
Shanghai Haishun New Pharmaceutical Packaging Co Ltd
SZSE:300501
Net Income (Common)
¥110.2m
CAGR 3-Years
6%
CAGR 5-Years
9%
CAGR 10-Years
N/A
C
China Hongqiao Group Ltd
HKEX:1378
Net Income (Common)
¥11.5B
CAGR 3-Years
3%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Shandong Nanshan Aluminium Co Ltd
SSE:600219
Net Income (Common)
¥3.5B
CAGR 3-Years
19%
CAGR 5-Years
19%
CAGR 10-Years
16%
A
Aluminum Corporation of China Ltd
SSE:601600
Net Income (Common)
¥6.7B
CAGR 3-Years
141%
CAGR 5-Years
52%
CAGR 10-Years
22%
Yunnan Aluminium Co Ltd
SZSE:000807
Net Income (Common)
¥4B
CAGR 3-Years
64%
CAGR 5-Years
N/A
CAGR 10-Years
74%
Tianshan Aluminum Group Co Ltd
SZSE:002532
Net Income (Common)
¥2.2B
CAGR 3-Years
5%
CAGR 5-Years
76%
CAGR 10-Years
34%

See Also

What is Shanghai Haishun New Pharmaceutical Packaging Co Ltd's Net Income (Common)?
Net Income (Common)
110.2m CNY

Based on the financial report for Sep 30, 2023, Shanghai Haishun New Pharmaceutical Packaging Co Ltd's Net Income (Common) amounts to 110.2m CNY.

What is Shanghai Haishun New Pharmaceutical Packaging Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
9%

Over the last year, the Net Income (Common) growth was 1%. The average annual Net Income (Common) growth rates for Shanghai Haishun New Pharmaceutical Packaging Co Ltd have been 6% over the past three years , 9% over the past five years .